Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Elitek

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
To the Editor: A recent letter in this journal described methemoglobinemia and hemolysis due to rasburicase in a patient with… Expand
2002
2002
  • The Medical letter on drugs and therapeutics
  • 2002
  • Corpus ID: 36661054
 
Review
2002
Review
2002
  • C. Pui
  • Expert opinion on pharmacotherapy
  • 2002
  • Corpus ID: 24611427
Rasburicase (Fasturtec®, Elitek™, Sanofi-Synthelabo) is a new recombinant urate oxidase developed for the prevention and… Expand
2002
2002
The FDA recently approved rasburicase (Elitek, Sanofi-Synthelabo), one of the few drugs to be tested in clinical studies largely… Expand